EPO (epoetin) approval stirs cost concern in Congress.
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D003365:Costs and Cost Analysis; D004921:Erythropoietin / Q000096:biosynthesis*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000188:drug therapy; D007880:Legislation, Drug; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration